Predictive value of H2 FPEF score in patients with heart failure with preserved ejection fraction

Yuxi Sun; Niuniu Wang; Xiao Li; Yanli Zhang; Jie Yang; Gary Tse; Ying Liu

doi:10.1002/ehf2.13187

Predictive value of H₂ FPEF score in patients with heart failure with preserved ejection fraction

ESC Heart Fail. 2021 Apr;8(2):1244-1252. doi: 10.1002/ehf2.13187. Epub 2021 Jan 5.

Authors

Yuxi Sun¹, Niuniu Wang², Xiao Li³, Yanli Zhang¹, Jie Yang⁴, Gary Tse¹, Ying Liu¹

Affiliations

¹ Heart Failure and Structural Cardiology Division, Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, 193 United Road, Dalian, Liaoning, 116021, China.
² Department of Cardiology, The Second Affiliated Hospital of Xuzhou Medical University, NO. 32 Meijian Road, Xuzhou, Jiangsu, 221000, China.
³ Department of Cardiology, Second Xiangya Hospital of Central South University, 139 Middle Renmin Road, Changsha, Hunan, 410011, China.
⁴ School of Public Health, Dalian Medical University, No. 9 W. Lvshun South Road, Dalian, Liaoning, 116044, China.

Abstract

Aims: The H₂ FPEF score is a convenient risk stratification tool for diagnosing heart failure with preserved ejection fraction (HFpEF). This study examined the value of the H₂ FPEF score for predicting all-cause mortality and rehospitalization in HFpEF patients.

Methods and results: This was a retrospective cohort study of patients diagnosed with HFpEF by echocardiography at a single tertiary centre between 1 January 2015 and 30 April 2018. According to the H₂ FPEF score, the subjects were divided into low (0-1 points), intermediate (2-5 points), and high (6-9 points) score groups. The primary outcomes were all-cause mortality and rehospitalization. A total of 476 patients (mean age: 70.5 ± 8.4 years, 60.7% female) were included. Of these, 47 (9.9%), 262 (55.0%), and 167 (35.1%) were classified into the low, intermediate, and high score groups, respectively. Over a mean follow-up of 27.5 months, 63 patients (13.2%) died, and 311 patients (65.3%) were rehospitalized. The mortality rates were 3 (6.4%), 29 (11.1%), and 31 (18.6%), and the number of patients with rehospitalization was 28 (59.6%), 159 (60.7%), and 124 (74.3%) for the low, intermediate, and high score groups, respectively. Multivariate Cox regression identified H₂ FPEF score as an independent predictor of all-cause mortality (hazard ratio [HR]: 1.46, 95% CI: 1.23-1.73, P < 0.0001) and rehospitalization (HR: 1.15, 95% CI: 1.08-1.22, P < 0.0001). Receiver operating characteristic (ROC) analysis demonstrated the H₂ FPEF score can effectively predict all-cause mortality (AUC 0.67, 95% CI: 0.60-0.73, P < 0.0001) and rehospitalization (AUC 0.59, 95% CI: 0.54-0.65, P = 0.001) after adjusting for age and NYHA class. With a cut-off value of 5.5, the sensitivity and specificity were 68.3% and 55.4% for all-cause mortality and 50.5% and 66.7% for rehospitalization.

Conclusions: The H₂ FPEF score can be used to predict prognosis in HFpEF patients. Higher scores are associated with higher all-cause mortality and rehospitalization.

Keywords: All-cause mortality; H2FPEF score; Heart failure with preserved ejection fraction; Rehospitalization; Risk stratification.

MeSH terms

Aged
Echocardiography
Female
Heart Failure* / diagnosis
Humans
Male
Middle Aged
Prognosis
Retrospective Studies
Stroke Volume